|
1
|
Gilligan D, Nicolson M, Smith I, et al:
Preoperative chemotherapy in patients with resectable non-small
cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012
multicentre randomised trial and update of systematic review.
Lancet. 369:1929–1937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Melet A, Song K, Bucur O, Jagani Z,
Grassian AR and Khosravi-Far R: Apoptotic pathways in tumor
progression and therapy. Adv Exp Med Biol. 615:47–79. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edinger AL and Thompson CB: Death by
design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol.
16:663–669. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boya P, Gonzalez-Polo RA, Casares N, et
al: Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol.
25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cuervo AM: Autophagy: in sickness and in
health. Trends Cell Biol. 14:70–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cuervo AM and Dice JF: A receptor for the
selective uptake and degradation of proteins by lysosomes. Science.
273:501–503. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ogier-Denis E and Codogno P: Autophagy: a
barrier or an adaptive response to cancer. Biochim Biophys Acta.
1603:113–128. 2003.PubMed/NCBI
|
|
9
|
Messina ME Jr and Halaby R: Does
triptolide induce lysosomal-mediated apoptosis in human breast
cancer cells? Med Hypotheses. 91932011.PubMed/NCBI
|
|
10
|
Yang GZ and Chen Y: The study development
of ester ethanol of common threewingnut root. J Chin Med Mater.
29:200–203. 2006.
|
|
11
|
Pan XD, Chen XC, Zhu YG, et al:
Tripchlorolide protects neuronal cells from microglia-mediated
beta-amyloid neurotoxicity through inhibiting NF-kappaB and JNK
signaling. Glia. 57:1227–1238. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holm E, Hildebrandt W, Kinscherf R and
Droge W: Low post-absorptive net protein degradation in male cancer
patients: lack of sensitivity to regulatory amino acids? Oncol Rep.
17:695–700. 2007.PubMed/NCBI
|
|
15
|
Hait WN, Jin S and Yang JM: A matter of
life or death (or both): understanding autophagy in cancer. Clin
Cancer Res. 12:1961–1965. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qu X, Yu J, Bhagat G, et al: Promotion of
tumorigenesis by heterozygous disruption of the beclin 1 autophagy
gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qian W, Liu J, Jin J, Ni W and Xu W:
Arsenic trioxide induces not only apoptosis but also autophagic
cell death in leukemia cell lines via up-regulation of Beclin-1.
Leuk Res. 31:329–339. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim KW, Mutter RW, Cao C, et al: Autophagy
for cancer therapy through inhibition of pro-apoptotic proteins and
mammalian target of rapamycin signaling. J Biol Chem.
281:36883–36890. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mijatovic S, Maksimovic-Ivanic D, Radovic
J, et al: Anti-glioma action of aloe emodin: the role of ERK
inhibition. Cell Mol Life Sci. 62:589–598. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Opipari AW Jr, Tan L, Boitano AE, Sorenson
DR, Aurora A and Liu JR: Resveratrol-induced autophagocytosis in
ovarian cancer cells. Cancer Res. 64:696–703. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hung JY, Hsu YL, Li CT, et al: 6-Shogaol,
an active constituent of dietary ginger, induces autophagy by
inhibiting the AKT/mTOR pathway in human non-small cell lung cancer
A549 cells. J Agric Food Chem. 57:9809–9816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tengchaisri T, Chawengkirttikul R,
Rachaphaew N, Reutrakul V, Sangsuwan R and Sirisinha S: Antitumor
activity of triptolide against cholangiocarcinoma growth in vitro
and in hamsters. Cancer Lett. 133:169–175. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang S, Chen J, Guo Z, et al: Triptolide
inhibits the growth and metastasis of solid tumors. Mol Cancer
Ther. 2:65–72. 2003.PubMed/NCBI
|
|
24
|
Phillips PA, Dudeja V, McCarroll JA, et
al: Triptolide induces pancreatic cancer cell death via inhibition
of heat shock protein 70. Cancer Res. 67:9407–9416. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Antonoff MB, Chugh R, Borja-Cacho D, et
al: Triptolide therapy for neuroblastoma decreases cell viability
in vitro and inhibits tumor growth in vivo. Surgery. 146:282–290.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mujumdar N, Mackenzie TN, Dudeja V, et al:
Triptolide induces cell death in pancreatic cancer cells by
apoptotic and autophagic pathways. Gastroenterology. 139:598–608.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Borja-Cacho D, Yokoyama Y, Chugh RK, et
al: TRAIL and triptolide: an effective combination that induces
apoptosis in pancreatic cancer cells. J Gastrointest Surg.
14:252–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng HT, Zhu L, Ni WM, You LS, Jin J and
Qian WB: Triptolide inhibits the proliferation of cells from
lymphocytic leukemic cell lines in association with downregulation
of NF-kappaB activity and miR-16-1*. Acta Pharmacol Sin.
32:503–511. 2011.PubMed/NCBI
|
|
29
|
Li J, Zhu W, Leng T, et al:
Triptolide-induced cell cycle arrest and apoptosis in human renal
cell carcinoma cells. Oncol Rep. 25:979–987. 2011.PubMed/NCBI
|
|
30
|
Wu PP, Liu KC, Huang WW, et al: Triptolide
induces apoptosis in human adrenal cancer NCI-H295 cells through a
mitochondrial-dependent pathway. Oncol Rep. 25:551–557.
2011.PubMed/NCBI
|
|
31
|
Lee KY, Park JS, Jee YK and Rosen GD:
Triptolide sensitizes lung cancer cells to TNF-related
apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition
of NF-kappaB activation. Exp Mol Med. 34:462–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
